Progenics Pharma (PGNX) Announces David Mims as Interim CEO
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today announced its Board of Directors has appointed David W. Mims as interim Chief Executive ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)